Medical Condition News

RSS

Loyola presents Scientist of the Year awards

Susan Baker, PhD, a leading researcher of a class of viruses that includes Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), has been named Senior Scientist of the Year at Loyola University Chicago Stritch School of Medicine. Wei Qiu, PhD, who is researching the molecular mechanisms of liver cancer, has been named Junior Scientist of the Year.

6 Nov 2015

New study compares effectiveness of clozapine with standard antipsychotics in adults with schizophrenia

In real-world settings, patients with schizophrenia whose symptoms do not respond to standard antipsychotic medications have better outcomes if they are switched to clozapine instead of another standard antipsychotic. They have fewer hospitalizations, stay on the new medication longer, and are less likely to need to use additional antipsychotics.

6 Nov 2015

Genetic reduction of AMPK enzyme can prevent or delay hearing loss

A mitochondrial defect is responsible for a type of human hereditary deafness that worsens over time and can lead to profound hearing loss.

6 Nov 2015

UCSF scientists identify eye drop chemical that may reverse cataracts

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

6 Nov 2015

New treatment may help patients with chronic renovascular disease

A new treatment may help patients with a chronic kidney condition that can also lead to heart problems and premature death, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

6 Nov 2015

Circulating protein predicts risk of chronic kidney disease

Make room, cholesterol. A new disease marker is entering the medical lexicon: suPAR, or soluble urokinase-type plasminogen activator receptor.

6 Nov 2015

Boxing more dangerous than mixed martial arts, shows study

Mixed martial arts has a reputation for being one of the most brutal and bloody of all contact sports, but the reality is boxing poses a greater risk of serious injury, according to new research from the University of Alberta.

6 Nov 2015

Hutchison MediPharma begins sulfatinib Phase I trial in US

Hutchison China MediTech Limited today announces that Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, has initiated the Phase I clinical trial of sulfatinib (HMPL-012) in the United States.

6 Nov 2015

Researchers identify potential brain-based biomarker for depressive symptoms

Approximately half of individuals who experience a traumatic brain injury (TBI) experience depression within a year.

6 Nov 2015

Combination of ultrasound and mammography detects additional cancers in Japanese women

Adding ultrasound to standard mammography tests in breast screening could result in improved rates of detection for breast cancer in women in Japan, according to a new study, published in The Lancet.

6 Nov 2015

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

With cancer survival rates in the UK persistently trailing comparable European countries, it’s time to admit to a national problem – and do something about it, says a leading expert at the Primary Care Society for Gastroenterology.

6 Nov 2015

Sedentary activity, inadequate intake of healthier foods can lead to obesity

Indulgences like sodas and junk foods have long been blamed as the prime culprits responsible for worrying obesity trends across the United States.

6 Nov 2015

Specific gut bacteria can improve cancer immunotherapy, show studies

By introducing a particular strain of bacteria into the digestive tracts of mice with melanoma, researchers at the University of Chicago were able to boost the ability of the animal's immune systems to attack tumor cells. T

6 Nov 2015

Clinical dietitian provides tips to reduce red meat consumption

When the World Health Organization (WHO)'s research division announced last week that processed meat and red meat cause cancer, Tina Colaizzo-Anas, associate professor in Buffalo State's Health, Nutrition and Dietetics Department and director of its Dietitian Education Program, was not surprised.

6 Nov 2015

MD Anderson Cancer Center, CytomX to study probody-enabled CAR-NK cell therapies

CytomX Therapeutics, a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today entered into a collaboration with The University of Texas MD Anderson Cancer Center to research Probody-enabled chimeric antigen receptor natural killer (CAR-NK) cell therapies, to be known as ProCAR-NK cell therapies.

6 Nov 2015

Researchers uncover important mechanism that could help protect against infection, allergy and cancer

New research has uncovered an important mechanism in the drive to understand immunological processes that protect us against infection, allergy and cancer.

5 Nov 2015

Computer algorithm may be useful in early diagnosis of schizophrenia

The opinion of a qualified professional is unlikely to be replaced by a computer algorithm for the diagnosis of schizophrenia. However, additional medical evidence based on such an algorithm might be useful in early diagnosis, according to work published in the International Journal of Intelligent Systems Technologies and Applications.

5 Nov 2015

Researchers discover potential solution for side effects of immunotherapy treatment for Alzheimer's

It is estimated that 46.8 million people worldwide are living with dementia, with Alzheimer's disease the most common form.

5 Nov 2015

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.

5 Nov 2015

University of Leicester awarded BBSRC grant to explore three key areas that impact human health

The University of Leicester has been awarded over £1.5 million in order to advance knowledge and understanding in three key areas that impact on health.

5 Nov 2015

Medical Condition News

Loyola presents Scientist of the Year awards

New study compares effectiveness of clozapine with standard antipsychotics in adults with schizophrenia

Genetic reduction of AMPK enzyme can prevent or delay hearing loss

UCSF scientists identify eye drop chemical that may reverse cataracts

New treatment may help patients with chronic renovascular disease

Circulating protein predicts risk of chronic kidney disease

Boxing more dangerous than mixed martial arts, shows study

Hutchison MediPharma begins sulfatinib Phase I trial in US

Researchers identify potential brain-based biomarker for depressive symptoms

Combination of ultrasound and mammography detects additional cancers in Japanese women

PCSG campaign highlights significance of family doctors in early gastroenterological cancer diagnosis

Sedentary activity, inadequate intake of healthier foods can lead to obesity

Specific gut bacteria can improve cancer immunotherapy, show studies

Clinical dietitian provides tips to reduce red meat consumption

MD Anderson Cancer Center, CytomX to study probody-enabled CAR-NK cell therapies

Researchers uncover important mechanism that could help protect against infection, allergy and cancer

Computer algorithm may be useful in early diagnosis of schizophrenia

Researchers discover potential solution for side effects of immunotherapy treatment for Alzheimer's

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

University of Leicester awarded BBSRC grant to explore three key areas that impact human health

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News